Hawaiian Tropic unveils new SPF products for winter and travel protection Hawaiian Tropic has launched its new Sheer Touch Face SPF 60+ and Lip Balm SPF 30, designed for versatile protection during winter and holiday travel. The Lip Balm, available in Pineapple and Island Coconut, features 12-hour hydration, Vitamin E, Shea Butter, and 80-minute water […]
December Launch Pad: Winter wonders in beauty and personal care Read More »
As 2024 comes to a close, the global cosmetics and personal care industry continues to evolve rapidly, with key developments shaping how brands, suppliers, and consumers interact. In this month’s Across the CD-Verse, we spotlight the latest insights and trends from CosmeticsDesign Asia, Europe, and the US, giving you a comprehensive overview of the industry’s
Across the CD-Verse: December 2024 Read More »
The roughly $1,000 monthly price tag of Eli Lilly‘s weight loss drug Zepbound put the blockbuster treatment out of reach for Willow Baillies, 29, whose insurance does not cover it. Baillies, a human resources specialist based in Milwaukee, Wisconsin, has been attempting to lose weight and dealing with chronic autoimmune issues for years, so she
Internal combustion engine (ICE) vehicles and electric vehicles (EVs) each have their pros and cons. From an environmental standpoint, EVs are the clear winner. But that’s not the only advantage. Uniquely designed, EVs can offer a host of benefits. The following five will be stand outs for executive fleets. #1 Additional Occupant
5 Unexpected Benefits of Electrifying Your Executive Fleet Read More »
Anyone who’s been on a diet can likely relate: Those first lost pounds are met with a sense of euphoria. The voice inside one’s head screams: “I’ve got this!” But then, it inevitably becomes a slog. The initial novelty wears off, and the real work begins. Investors may see a parallel to the initial elation
The 'weight-loss trade' has stalled. What it will take to revive investor interest Read More »
Eli Lilly has outperformed the S & P 500 for five straight years as Wall Street woke up to its massive opportunity in obesity drugs. Six in a row is not out of the question. Year-to-date performance: Up 33.7% Forward price-to-earnings ratio: 34.3 versus five-year average of 34.5 Our rating: Buy-equivalent 1 Our price target:
Eli Lilly looks to extend its winning streak over the broader market to 6 years Read More »
The safest choices drivers and passengers can make this holiday season are buckling up, driving sober, and looking out for others on the road. This year, AAA expects 119.3 million people will travel from home over the year-end holiday period, specifically between Tuesday, December 24, 2024, and Wednesday, January 1, 2025.
More Drivers, More Danger: Why This Holiday Season Could Be the Riskiest Yet Read More »
Retail used-vehicle listing prices have been consistently lower through the first 11 months of 2024 than year-ago levels. Used vehicle inventory levels at the start of December were unchanged from November but lower than in early December 2023 as used vehicle sales increased, according to the Cox Automotive analysis of vAuto Live Market
Used Vehicles: Sales Up, Days' Supply Down, Inventory Flat Read More »
The Food and Drug Administration on Friday approved Eli Lilly‘s blockbuster weight loss drug Zepbound for treating patients with the most common sleep-related breathing disorder, expanding its use and possibly its insurance coverage in the U.S. The weekly injection is now the first drug treatment option cleared for patients with obesity and moderate-to-severe obstructive sleep
How K-12 reforms and recent disruptions created Gen Z’s baffling habits. By Beckie Supiano Accountability and test-based reforms, pandemic-era disruptions, and larger social and economic pressures have fostered ineffective habits. Source link
How Changes in K-12 Schooling Hampered the Preparation of College Students Read More »
